Coverage of our peer-reviewed research and news reporting in the healthcare and mainstream press.
The Center for Value-Based Insurance Design (V-BID) highlighted an article from The American Journal of Managed Care® (AJMC®) in its 2017 fall update. The article, “VBID Summit Explores How Congress Can Make High-Deductible Plans Work for Consumers,” reported on the healthcare concept of VBID, which seeks to remove financial barriers for high-value care. The idea has been pioneered by the co-editors-in-chief of AJMC®, A. Mark Frederick, MD, of the University of Michigan and its V-BID Center, and Michael E. Chernew, PhD, of Harvard Medical School.
The National Pharmaceutical Council’s Daily Newsfeed e-mail on Friday highlighted an article published by AJMC®. The article, "ICER Reviews $13.9 Million Grant, Plans to Assess All New Drugs,” reported on The Institute for Clinical and Economic Review’s (ICER) announcement that they received a 3-year grant from the Laura and John Arnold Foundation (LJAF). ICER, a non-profit drug-pricing watchdog, plans to use the funds in support of its ongoing efforts to change the ways in which new prescription drugs are evaluated and priced.
A study published in AJMC® was mentioned on Advance Cardio Health’s Facebook page. The study, “Few Patients Prescribed PCSK9 Inhibitors Actually Receive the Therapy,” found that many patients who are prescribed PCSK9 inhibitors often face challenges involving patient access, including low approval rates during the first year of availability.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen